Drug trial gives hope of longer life to women fighting ovarian cancer

• Drug could be available within five years • First new treatment in a decade is by British teamBritish scientists have developed and clinically tested a drug that could prolong the lives of thousands of women suffering from one of the most aggressive cancers.Ovarian cancer kills 4,500 women a year and has proved particularly difficult to treat. It is more than a decade since medics have had a new weapon at their disposal with which to tackle the disease, but if further trials confirm the effectiveness of the new drug, it could be available within five years, say researchers. A clinical trial of the drug, codenamed CNTO328, has been carried out at Centre for Experimental Cancer Medicine, part of Barts and the London School of Medicine and Dentistry.Eight of the 18 women involved found their tumours stabilised or shrank while they were taking part, which should mean they live longer...

Read the whole article on The Guardian - Science

More from The Guardian - Science

Related